Wiener klinische Wochenschrift

, Volume 130, Issue 13–14, pp 456–457 | Cite as

MUW researcher of the month

  • Philipp Wohlfarth
MUW researcher of the month


  1. 1.
    Passweg JR, Baldomero H, Bader P, Bonini C, Cesaro S, Dreger P, Duarte RF, Dufour C, Kuball J, Farge-Bancel D, et al. Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually. Bone Marrow Transplant. 2016;51(6):786–92.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Yadav H, Nolan ME, Bohman JK, Cartin-Ceba R, Peters SG, Hogan WJ, Gajic O, Kor DJ. Epidemiology of Acute Respiratory Distress Syndrome Following Hematopoietic Stem Cell Transplantation. Crit Care Med. 2016;44(6):1082–90CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Azoulay E, Lemiale V, Mokart D, Pene F, Kouatchet A, Perez P, Vincent F, Mayaux J, Benoit D, Bruneel F, et al. Acute respiratory distress syndrome in patients with malignancies. Intensive Care Med. 2014;40(8):1106–14.CrossRefPubMedGoogle Scholar
  4. 4.
    Schmidt M, Brechot N, Combes A. Ten situations in which ECMO is unlikely to be successful. Intensive Care Med. 2016;42(5):750–2CrossRefPubMedGoogle Scholar
  5. 5.
    Staudacher DL, Bode C, Wengenmayer T. Four situations in which ECMO might have a chance. Intensive Care Med. 2016;42(8):1305–6.CrossRefPubMedGoogle Scholar
  6. 6.
    Park PK. Extracorporeal Membrane Oxygenation Support Following Stem Cell Transplant-When Is All That We Have Still Not Enough? Crit Care Med. 2017;45(5):925–6.CrossRefPubMedGoogle Scholar
  7. 7.
    Wohlfarth P, Beutel G, Lebiedz P, Stemmler HJ, Staudinger T, Schmidt M, Kochanek M, Liebregts T, Taccone FS, Azoulay E, et al. Characteristics and Outcome of Patients After Allogeneic Hematopoietic Stem Cell Transplantation Treated With Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome. Crit Care Med. 2017;45(5):e500–e7.CrossRefPubMedGoogle Scholar
  8. 8.
    Wohlfarth P, Ullrich R, Staudinger T, Bojic A, Robak O, Hermann A, Lubsczyk B, Worel N, Fuhrmann V, Schoder M, et al. Extracorporeal membrane oxygenation in adult patients with hematologic malignancies and severe acute respiratory failure. Crit Care. 2014;18(1):R20.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Wohlfarth P, Agis H, Gualdoni GA, Weber J, Staudinger T, Schellongowski P, Robak O. Interleukin-1 receptor antagonist anakinra, intravenous immunoglobulin and corticosteroids in the management of critically ill adult patients with hemophagocytic lymphohistiocytosis. J Intensive Care Med. 2017. PubMedCrossRefGoogle Scholar
  10. 10.
    Wohlfarth P, Carlstrom A, Staudinger T, Clauss S, Hermann A, Rabitsch W, Bojic A, Skrabs C, Porpaczy E, Schiefer AI, et al. Incidence of intensive care unit admission, outcome and post intensive care survival in patients with diffuse large B-cell lymphoma. Leuk Lymphoma. 2016;57(8):1831–8.CrossRefPubMedGoogle Scholar
  11. 11.
    Wohlfarth P, Staudinger T, Sperr WR, Bojic A, Robak O, Hermann A, Laczika K, Carlstrom A, Riss K, Rabitsch W, et al. Prognostic factors, long-term survival, and outcome of cancer patients receiving chemotherapy in the intensive care unit. Ann Hematol. 2014;93(10):1629–36.CrossRefPubMedGoogle Scholar
  12. 12.
    Wohlfarth P, Turki A, Steinmann J, Fiedler M, Steckel NK, Beelen DW, Liebregts T. Microbiological diagnostic work-up of acute respiratory failure with pulmonary infiltrates following allogeneic hematopoietic stem cell transplantation: findings in the era of molecular and biomarker-based assays. Biol Blood Marrow Transplant. 2018. CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Austria, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Einrichtung für Knochenmark- und Stammzelltransplantation, Universitätsklinik für Innere Medizin IMedizinische Universität WienWienÖsterreich

Personalised recommendations